{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:45:55Z","timestamp":1790934355789,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.bone.2007.06.004","type":"journal-article","created":{"date-parts":[[2007,6,17]],"date-time":"2007-06-17T23:32:29Z","timestamp":1182123149000},"page":"346-352","source":"Crossref","is-referenced-by-count":107,"title":["Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates"],"prefix":"10.1016","volume":"41","author":[{"given":"C.B.","family":"Confavreux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Guastalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2007.06.004_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bone.2007.06.004_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.bjc.6603316","article-title":"Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?","volume":"95","author":"Leary","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"9114","key":"10.1016\/j.bone.2007.06.004_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"351","author":"EBCTCG","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bone.2007.06.004_bib4","article-title":"Tamoxifen for early breast cancer","author":"Cochrane","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.bone.2007.06.004_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-8529(02)00057-9","article-title":"Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis","volume":"32","author":"Fontana","year":"2003","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.bone.2007.06.004_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1\u20135","key":"10.1016\/j.bone.2007.06.004_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsbmb.2005.04.015","article-title":"Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations","volume":"95","author":"Geisler","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"24","key":"10.1016\/j.bone.2007.06.004_bib8","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra023246","article-title":"Aromatase inhibitors in breast cancer","volume":"348","author":"Smith","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2007.06.004_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","article-title":"Aromatase inhibitors in the treatment and prevention of breast cancer","volume":"19","author":"Goss","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bone.2007.06.004_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"9484","key":"10.1016\/j.bone.2007.06.004_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.bone.2007.06.004_bib12","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1200\/JCO.2005.04.120","article-title":"Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial","volume":"23","author":"Boccardo","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"9324","key":"10.1016\/j.bone.2007.06.004_bib13","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bone.2007.06.004_bib14","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"issue":"9453","key":"10.1016\/j.bone.2007.06.004_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.bone.2007.06.004_bib16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.bone.2007.06.004_bib17","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Thurlimann","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2007.06.004_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1359\/jbmr.1997.12.4.683","article-title":"Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort","volume":"12","author":"Arlot","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2007.06.004_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"58","key":"10.1016\/j.bone.2007.06.004_bib20","first-page":"99","article-title":"Evaluation de la teneur en calcium du r\u00e9gime alimentaire par autoquestionnaire fr\u00e9quentiel","author":"Fardelone","year":"1991","journal-title":"Rev. Rhum. Mal. Osteo-artic."},{"issue":"8","key":"10.1016\/j.bone.2007.06.004_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"ATAC Trialists' group. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)","volume":"21","author":"Eastell","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2007.06.004_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bone.2006.06.027","article-title":"Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane","volume":"40","author":"Gonnelli","year":"2007","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.bone.2007.06.004_bib23","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","article-title":"Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer","volume":"23","author":"Lonning","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.bone.2007.06.004_bib24","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17","volume":"24","author":"Perez","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bone.2007.06.004_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01811242","article-title":"Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years","volume":"12","author":"Love","year":"1988","journal-title":"Breast Cancer Res. Treat."},{"issue":"17","key":"10.1016\/j.bone.2007.06.004_bib26","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.ejca.2006.07.005","article-title":"Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study","volume":"42","author":"Geisler","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.bone.2007.06.004_bib27","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"1\u20135","key":"10.1016\/j.bone.2007.06.004_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsbmb.2005.04.010","article-title":"Aromatase inhibitors: cellular and molecular effects","volume":"95","author":"Miller","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bone.2007.06.004_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","article-title":"Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study","volume":"15","author":"Delmas","year":"1997","journal-title":"J. Clin. Oncol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328207005108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328207005108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T23:50:51Z","timestamp":1556495451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328207005108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S8756328207005108"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2007.06.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}